Anti-ORMDL3 antibody
0
(1 리뷰)
|
(5 제품이 사용된 논문 )
Rabbit Polyclonal ORMDL3 antibody. Suitable for IHC-P, WB and reacts with Human, Mouse samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human ORMDL3 aa 50-100 conjugated to Keyhole Limpet Haemocyanin.
대체 명칭 보기
ORM1-like protein 3, ORMDL3
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ORMDL3 antibody (AB211522)
Immunohistochemical analysis of Human spleen tissue labeling ORMDL3 with ab211522 at a 1/100 dilution. Heat mediated antigen retrieval used.
Reactivity 정보
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ORMDL3 modulates lipid metabolism and immune response regulation. It does this by being part of a regulatory complex with the serine palmitoyltransferase therefore influencing the production of sphingolipids which are essential components of cell membranes and contribute to cell signaling. Alterations in sphingolipid levels can affect membrane integrity and cell communication impacting cellular function and health.
Pathways
ORMDL3 influences sphingolipid metabolic processes and endoplasmic reticulum stress responses. In the sphingolipid metabolism pathway it directly interacts with SPTLC1 and SPTLC2 core components of the serine palmitoyltransferase enzyme complex. Additionally ORMDL3 indirectly affects the unfolded protein response pathway by influencing levels of sphingolipids which play a role in stress signaling in the endoplasmic reticulum.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (5)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Phenomics (Cham, Switzerland) 3:485-495 PubMed37881318
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 28: PubMed37594074
2023
Applications
Unspecified application
Species
Unspecified reactive species
IET nanobiotechnology 17:182-196 PubMed36680386
2023
Applications
Unspecified application
Species
Unspecified reactive species
Medical oncology (Northwood, London, England) 39:159 PubMed35972600
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 9:483 PubMed29706629
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com